Navigation Links
Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects
Date:3/4/2013

NEW YORK, March 4, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects

http://www.reportlinker.com/p01109062/Prefilled-Syringes-to-2018---Devices-Drugs-Markets-Players-and-Prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Highlights • Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics

• Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

• Examines design factors, material selection issues, technologies and market development issues

• Charts product data, market share, and forecasts to 2018

• Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents Executive Summary

Injectable Drug Market Dynamics

Competitive Landscape

The Device Manufacturing Universe

Supply Chain Dynamics

Supply Chain Structure

Supplier Relationships and Supply Risk

Supplier Integration

Captive Capacity vs CMOs

Demand Drivers

Drug Discovery and Development Trends

Patient and Caregiver Sentiment

Diseases and Indications

Patient Demographics

The Prefilled Syringe Ecosystem and Supply Chain

Materials and Components

Evolving Technology

Alliances & Relationships

Syringe Manufacturers

Technology/Capabilities

Geographic Reach

Barriers to Entry

CMO's – Beyond Fill & Finish

Value-added Services

Market Proximity

CMO Evolution

Testing, Services and Validation

Prefilled Syringes – Design Factors

Drug Stability and Shelf Life

Material Selection Issues

Point-of-Use Reconstitution

Caregiver Safety

Needle Configuration Strategies

Human Engineering/Ergonomics

Prefilled Syringes – Commercial Devices

Prefillable Therapeutic Injectables

Glass Prefillable Syringes

Plastic Prefillable Syringes

Ready-to-Fill Safety Syringes

Specialty Prefillable SyringesFlush SyringesDiluent SyringesImaging Agent Syringes

Competing Prefilled Devices

Bundled PFS + Autoinjector

Prefilled Pen Injectors

Prefilled Needle-free Injectors

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

AnaphylaxisAnticoagulantsAutoimmune DiseasesEmergency MedicineHepatitisHematopoietics and Related Erythropoiesis Stimulating ProteinsMetabolic Diseases NeurologyReproductive HealthVaccines?Non-API Prefilled Syringe Segments

Catheterization

Reconstitution

Diagnostic Imaging?

Market Factors

Self-Administration and Patient Compliance

Insurance, Reimbursement, and Managed Care

Regulatory Guidance and Product Approvals

The Evolving PFS Ecosystem

Prefilled Syringes – Market Participant Profiles

To order this report:Drug_Delivery_Technology Industry: Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects

Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
2. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
3. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
4. Microneedle Drug Patches, Syringes & Systems
5. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
6. Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan
7. BD Announces Agreement to Acquire Safety Syringes, Inc.
8. Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
9. Brazil Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
10. United Kingdom Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
11. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 2017  BioDigital, Inc., creators of the BioDigital ... 3D body mapping technology with eClinicalWorks, a privately ... will be used to capture and present dermatology ... human body. BioDigital pilots show using a body ... increasing the precision of clinical annotations compared to ...
(Date:2/17/2017)... -- Noble Capital Markets announced today that it has initiated ... EPIX ). The report was issued by Noble,s Head ... ESSA Pharmaceuticals is a clinical stage biopharmaceutical company ... lead compound EPI-506, is a small molecule oral drug ... receptor, thereby has potential to overcome some of the ...
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... February 19, 2017 , ... Orbita, ... join forces with Healthwise ® at HIMSS 2017 to showcase ... in evidence-based health education, technology and services, will demonstrate a voice-powered knowedge assistant ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette ... the Pet Life Radio network. The episode, which was posted this week, features ... what factors led to Park Cities Pet Sitter’s being awarded the 2017 National Association ...
(Date:2/17/2017)... ... 17, 2017 , ... The Alliance Healthcare Foundation (AHF) announced ... positively impact the health and wellness of our community in San Diego and ... to seriously consider releasing our assets beyond our 5% targeted distribution each year ...
(Date:2/17/2017)... VA (PRWEB) , ... February 17, 2017 , ... ... the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 ... , Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? , ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... executives and focusing on all facets of clinical trial planning and management. Pharmica ... patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were able ...
Breaking Medicine News(10 mins):